Cellebrite DI (CLBT) Revenue (2020 - 2025)

Cellebrite DI (CLBT) has reported Revenue for 6 consecutive years, with $128.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Revenue rose 18.13% year-over-year to $128.8 million; the TTM figure through Dec 2025 stood at $475.7 million (up 18.56% YoY), while the FY2025 annual figure was $475.7 million, up 18.56% from the prior year.
• Revenue came in at $128.8 million for Q4 2025 at Cellebrite DI, up from $126.0 million in the prior quarter.
• The five-year high for Revenue was $128.8 million in Q4 2025, with the low at $53.3 million in Q1 2021.
• Average Revenue over 5 years is $85.9 million, with a median of $80.4 million recorded in 2023.
• Across the five-year window, Revenue advanced 5.75% in 2022 and climbed 26.94% in 2024, its largest moves.
• Year by year, Revenue stood at $67.9 million in 2021, then advanced by 9.0% to $74.0 million in 2022, then advanced by 25.66% to $93.0 million in 2023, then gained by 17.24% to $109.0 million in 2024, then rose by 18.13% to $128.8 million in 2025.
• According to Business Quant data, Revenue over the past three periods registered $128.8 million, $126.0 million, and $113.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.